Themis Medicare Ltd. (THEMISMED) Share Price Rises 9.01% Today

Themis Medicare Ltd. Share Price rose 9.01% today, reaching Rs 116.7 with a market cap of Rs 968.89 Cr.

Themis Medicare Ltd. Share Price has seen a significant rise today, closing at Rs 116.7, marking a 9.01% increase from its previous close of Rs 107.05. This price movement places the company firmly in the spotlight, especially given its micro-cap status with a market capitalisation of Rs 968.89 crore. The day’s trading saw the stock open at Rs 107.05, reaching a high of Rs 117 and a low of Rs 105.15, with a total volume of 158,330 shares traded across BSE and NSE. Despite

Themis Medicare Ltd. (THEMISMED) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 116.7
Previous Close	Rs 107.05
Today's Change	+Rs 9.65 (+9.01%)
Day Open	Rs 107.05
Day High	Rs 117
Day Low	Rs 105.15
Current Volume (BSE)	6,747
BSE Traded Volume	6,747
NSE Traded Volume	1,51,583
Combined NSE + BSE Volume	1,58,330
Turnover	Rs 0.08 crore
Market Capitalisation	Rs 968.89 crore
Market Cap Category	Micro Cap

Themis Medicare Ltd. (THEMISMED) traded at Rs 116.7. versus the previous close of Rs 107.05, a rise of 9.01%. The stock opened at Rs 107.05, reached Rs 117, touched Rs 105.15. Reported volume was 6,747.

Themis Medicare Ltd. (THEMISMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 968.89 crore
P/E Ratio	-75.78x
P/B Ratio	3.67x
ROE	17.82%
ROCE	18.44%
EPS	Rs -1.54
Dividend Yield	0.47%

Themis Medicare Ltd. was valued at a P/E ratio of -75.78x, a P/B ratio of 3.67x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 17.82% and ROCE of 18.44%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -1.54, dividend yield of 0.47%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Themis Medicare Ltd. operates within the healthcare sector, specifically in the pharmaceuticals and drugs industry. The company has a market capitalisation of Rs 968.89 crore and an enterprise value that reflects its financial standing. The P/E ratio stands at -75.78, indicating that the company is currently not profitable, as earnings per share (EPS) is reported at -1.54. The P/B ratio is 3.67, suggesting a higher valuation relative to its book value. The return on equity (ROE) is 17.82%, while the return on capital employed (ROCE) is 18.44%, both of which are above the industry averages, indicating efficient use of capital. The dividend yield is modest at 0.47%, reflecting a conservative payout policy. These fundamentals provide a mixed picture, with strong capital returns but challenges in profitability. Investors may find the company’s valuation metrics and capital efficiency noteworthy, especially in comparison to its industry peers.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	-75.78x
Benchmark Median P/E	25.88x
Benchmark Average P/E	69.32x
Benchmark P/E Range	3.41x to 3,364.06x
Company P/B Ratio	3.67x
Benchmark Median P/B	1.77x
Company ROE	17.82%
Benchmark Median ROE	10.7%
Company ROCE	18.44%
Benchmark Median ROCE	12.98%
Company Market Capitalisation	Rs 968.89 crore
Benchmark Median Market Cap	Rs 146.46 crore

Themis Medicare Ltd. (THEMISMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Themis Medicare Ltd. (THEMISMED) has a P/E ratio of -75.78x, which is below the benchmark median of 25.88x, a difference of -392.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Themis Medicare Ltd. (THEMISMED) has a ROE of 17.82%, which is above the benchmark median of 10.7%, a difference of +66.54%. Themis Medicare Ltd. (THEMISMED) has a ROCE of 18.44%, which is above the benchmark median of 12.98%, a difference of +42.06%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Themis Medicare Ltd. is part of the healthcare sector, specifically within the pharmaceuticals and drugs industry. The sector benchmark includes 137 companies, providing a comprehensive context for comparison. The company’s P/E ratio of -75.78 is significantly below the industry median of 25.88, highlighting its current unprofitability. The P/B ratio of 3.67 is above the industry median of 1.77, indicating a higher valuation relative to its peers. The ROE of 17.82% and ROCE of 18.44% are both above the industry medians of 10.7% and 12.98%, respectively, showcasing strong capital efficiency. The market capitalisation of Rs 968.89 crore places Themis Medicare Ltd. above the industry median of Rs 146.46 crore, reflecting its relative size within the sector. These metrics provide a nuanced view of the company’s position within the healthcare industry, highlighting both its strengths and areas for improvement.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,931.84	0	0.76	-2.89	-0.26
Hikal Ltd.	HIKAL	2,731.11	0	2.37	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.39	7.98	28.21	26.35
Panacea Biotec Ltd.	PANACEABIO	2,580.49	0	9.08	0	5.36
Beta Drugs Ltd.	BETA	2,474.26	62.88	9.95	18.65	22.17

Themis Medicare Ltd. (THEMISMED) has a P/E ratio of -75.78x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.82% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 18.44% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Themis Medicare Ltd. (THEMISMED) has a market capitalisation of Rs 968.89 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Themis Medicare Ltd.

Investors are closely monitoring Themis Medicare Ltd. due to its recent price rise and unique market position.

• Price Action: The stock rose 9.01% today, surpassing the micro-cap threshold.
• Technical Position: The RSI indicates neutral momentum at 42.74.
• Fundamental Context: Strong ROE and ROCE despite negative EPS.
• Sector Positioning: Above-average capital efficiency in the healthcare sector.

As Themis Medicare Ltd. continues to navigate its market environment, investors should monitor its profitability trends and sector dynamics for further insights.

About Themis Medicare Ltd.

Themis Medicare Ltd. is a prominent player in the healthcare sector, focusing on the pharmaceuticals and drugs industry. The company is involved in the development, manufacturing, and marketing of a wide range of pharmaceutical products. With a market capitalisation of Rs 968.89 crore, Themis Medicare Ltd. operates in a competitive landscape, striving to deliver innovative healthcare solutions. The company’s product portfolio includes various therapeutic categories, catering to diverse medical needs. As a micro-cap entity, it faces both opportunities and challenges in scaling its operations and enhancing profitability. Themis Medicare Ltd. remains committed to advancing healthcare through its research-driven approach and strategic market positioning.

Track Themis Medicare Ltd. Share Price on Univest

Use Themis Medicare Ltd. (THEMISMED) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and analysts can track Themis Medicare Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share price movements, technical indicators, fundamental ratios, and shareholding patterns. Users can also explore 52-week levels and gain valuable market insights to make informed decisions. Stay updated with the latest developments in Themis Medicare Ltd.’s stock performance through Univest’s platform.

Frequently Asked Questions

What was Themis Medicare Ltd.'s share price increase today?

Ans. Themis Medicare Ltd.'s share price increased by 9.01% today, closing at Rs 116.7. This rise positions the company as a top gainer in the healthcare sector. The stock moved 9.01% during the session.

What is Themis Medicare Ltd.'s current market capitalisation?

Ans. Themis Medicare Ltd.'s current market capitalisation is Rs 968.89 crore, reflecting its status as a micro-cap company within the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is -75.78x.

How does Themis Medicare Ltd.'s P/E ratio compare to the industry?

Ans. Themis Medicare Ltd.'s P/E ratio is -75.78, significantly below the industry median of 25.88, indicating current unprofitability. The company trades at a P/E ratio of -75.78x. Its P/B ratio is 3.67x.

What are Themis Medicare Ltd.'s ROE and ROCE?

Ans. Themis Medicare Ltd. has an ROE of 17.82% and a ROCE of 18.44%, both above industry averages, showcasing strong capital efficiency. ROE stands at 17.82%. ROCE stands at 18.44%. The relevant peer median ROE is 10.7%.

How does Themis Medicare Ltd.'s P/B ratio compare to peers?

Ans. Themis Medicare Ltd.'s P/B ratio of 3.67 is competitive, especially when compared to peers like Kwality Pharmaceuticals Ltd. (7.98). The company trades at a P/E ratio of -75.78x. Its P/B ratio is 3.67x.

How does Themis Medicare Ltd.'s market cap compare to the industry median?

Ans. Themis Medicare Ltd.'s market cap of Rs 968.89 crore is above the industry median of Rs 146.46 crore, indicating its relative size. The company operates in the Healthcare sector. Its P/E ratio is -75.78x.

What sector does Themis Medicare Ltd. operate in?

Ans. Themis Medicare Ltd. operates in the healthcare sector, specifically within the pharmaceuticals and drugs industry, focusing on innovative healthcare solutions. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.